4.6 Use in special populations Pregnancy and Lactation Maxiliv tablet should not be administered to a pregnant and lactating woman unless clinical benefit outweighs the risks
Several tests were conducted on the tumour tissue upon patient diagnosis
doi:10.1586/ern.12.15 Stojanovski S, Scratch SE, Dunkley BT, Schachar R, Wheeler AL
Last reviewed: June 20, 2026 Last updated: June 20, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Its imbalanced receptor affinity and biased signaling provide enhanced insulin secretion and improved metabolic outcomes beyond selective GLP-1 agonism
Han YH, Kim SZ, Kim SH, Park WH